Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

NCT01088737 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Medical University of Graz